
Glutathione Market Demand, Size, Scope and Competitive Analysis 2022-2032
Glutathione Market Size- By Type, By Product, By Application- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032
Published: Nov-2022 | Report ID: CHEM2208 | Pages: 1 - 250 | Formats*: |
Category : Chemical & Materials |
-010020517032023.jpg)
-010021217032023.jpg)
Report Metric | Details |
Market size available for years | 2019-2032 |
Base year considered | 2021 |
Forecast period | 2022-2032 |
Segments covered | By Type, By Product, By Application |
Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Companies Covered | Bio-Rad Laboratories Inc., Cytiva, Jarrow Formulas Inc., Kaiping Genuine Biochemical Pharmaceutical Co. Ltd., Kohjin Life Sciences Co. Ltd., Kyowa Hakko Bio Co. Ltd., Merck KGaA, Mitsubishi Corporation Life Sciences Ltd., Nissor Pharmaceuticals Ltd., Shandong Jincheng Biological Pharmaceutical Co. Ltd., Shenzhen GSH Bio-Technology Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc. |
1.1. Scope of the report1.2. Market segment analysis
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data2.1.3 SPER’s internal database2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1 Drivers4.1.2 Restraints4.1.3 Opportunities4.1.4 Challenges4.2. COVID-19 Impacts of the Global Glutathione Market
5.1. SWOT analysis
5.1.1 Strengths5.1.2 Weaknesses5.1.3 Opportunities5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape5.2.2 Economic landscape5.2.3 Social landscape5.2.4 Technological landscape5.2.5 Environmental landscape5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers5.3.2 Bargaining power of Buyers5.3.3 Threat of Substitute5.3.4 Threat of new entrant5.3.5 Competitive rivalry
5.4. Heat map analysis
6.1. L-Glutathione6.2. Acetyl-Glutathione
7.1. Oxidized Glutathione7.2. Reduced Glutathione
8.1. Food & Beverages8.2. Immunoprecipitation (IP)8.3. Personal Care & Cosmetics8.4. Pharmaceuticals8.5. Protein Purification8.6. Research8.7. Others
9.1 North America
9.1.1 United States9.1.2 Canada9.1.3 Mexico
9.2 Europe
9.2.1 Germany9.2.2 United Kingdom9.2.3 France9.2.4 Italy9.2.5 Spain9.2.6 Rest of Europe
9.3 Asia-Pacific
9.3.1 China9.3.2 Japan9.3.3 India9.3.4 Australia9.3.5 South Korea9.3.6 Rest of Asia-Pacific
9.4 South America
9.4.1 Brazil9.4.2 Argentina9.4.3 Rest of South America
9.5 Middle East & Africa
9.5.1 Kingdom of Saudi Arabia9.5.2 United Arab Emirates9.5.3 Rest of Middle East & Africa
10.1 Bio-Rad Laboratories Inc.
10.1.1 Company details10.1.2 Financial outlook10.1.3 Product summary10.1.4 Recent developments
10.2 Cytiva
10.2.1 Company details10.2.2 Financial outlook10.2.3 Product summary10.2.4 Recent developments
10.3 Jarrow Formulas Inc.
10.3.1 Company details10.3.2 Financial outlook10.3.3 Product summary10.3.4 Recent developments
10.4 Kaiping Genuine Biochemical Pharmaceutical Co. Ltd.
10.4.1 Company details10.4.2 Financial outlook10.4.3 Product summary10.4.4 Recent developments
10.5 Kohjin Life Sciences Co. Ltd.
10.5.1 Company details10.5.2 Financial outlook10.5.3 Product summary10.5.4 Recent developments
10.6 Kyowa Hakko Bio Co. Ltd.
10.6.1 Company details10.6.2 Financial outlook10.6.3 Product summary10.6.4 Recent developments
10.7 Merck KGaA
10.7.1 Company details10.7.2 Financial outlook10.7.3 Product summary10.7.4 Recent developments
10.8 Mitsubishi Corporation Life Sciences Ltd.
10.8.1 Company details10.8.2 Financial outlook10.8.3 Product summary10.8.4 Recent developments
10.9 Nissor Pharmaceuticals Ltd.
10.9.1 Company details10.9.2 Financial outlook10.9.3 Product summary10.9.4 Recent developments
10.10 Shandong Jincheng Biological Pharmaceutical Co. Ltd.
10.10.1 Company details10.10.2 Financial outlook10.10.3 Product summary10.10.4 Recent developments
10.11 Shenzhen GSH Bio-Technology Co. Ltd.
10.11.1 Company details10.11.2 Financial outlook10.11.3 Product summary10.11.4 Recent developments
10.12 Takara Bio Inc.
10.12.1 Company details10.12.2 Financial outlook10.12.3 Product summary10.12.4 Recent developments
10.13 Thermo Fisher Scientific Inc.
10.13.1 Company details10.13.2 Financial outlook10.13.3 Product summary10.13.4 Recent developments
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment






Related Reports
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.